OAC
CRBP icon

OMERS Administration Corp’s Corbus Pharmaceuticals CRBP Stock Holding History

OMERS Administration Corp’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$143K Sell
15,200
-14,800
-49% -$125K ﹤0.01% 969
2025
Q4 		$244K Buy
+30,000
New +$370K ﹤0.01% 865

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

OMERS Administration Corp's CRBP Position: Q1 2026 in Review

OMERS Administration Corp reduced its Corbus Pharmaceuticals (CRBP) stake by 49% in Q1 2026, selling an estimated $125K and leaving 15,200 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #969.

OMERS Administration Corp first reported a position in CRBP in Q4 2025 and has held it in 2 quarters since. The position peaked at $244K in Q4 2025. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • OMERS Administration Corp held 15,200 shares of Corbus Pharmaceuticals worth $143K as of Q1 2026.
  • OMERS Administration Corp sold 14,800 Corbus Pharmaceuticals shares in Q1 2026, an estimated $125K.
  • Corbus Pharmaceuticals made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #969 holding.
  • OMERS Administration Corp first reported a position in Corbus Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • OMERS Administration Corp's Corbus Pharmaceuticals position peaked at $244K in Q4 2025.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.